SNCA and Parkinson disease: In the search for a PD biomarker beyond the predominantly clinical diagnosis of pPD, the role of tissue biopsies in assessing the presence of pathological α-synuclein (α-syn) in vivo has gained considerable scientific attention in recent years (5).